2014
DOI: 10.1111/apt.12986
|View full text |Cite
|
Sign up to set email alerts
|

Extra‐hepatic manifestations of autochthonous hepatitis E infection

Abstract: Summary Background Autochthonous (locally acquired) hepatitis E is increasingly recognised in developed countries, and is thought to be a porcine zoonosis. A range of extra‐hepatic manifestations of hepatitis E infection have been described, but have never been systematically studied. Aim To report the extra‐hepatic manifestations of hepatitis E virus. Methods Retrospective review of data of 106 cases of autochthonous hepatitis E (acute n = 105, chronic n = 1). Results Eight (7.5%) cases presented with neurolo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
115
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 133 publications
(127 citation statements)
references
References 29 publications
3
115
0
Order By: Relevance
“…These complications include neurological disorders (Kamar et al 2011;Cheung et al 2012;Santos et al 2013;van den Berg et al 2014;Woolson et al 2014), myasthenia gravis (Belbezier et al 2014), thrombocytopenia (Fourquet et al 2010), aplastic anemia (Shah et al 2012) glomerulonephritis (Kamar et al 2012) and acute pancreatitis (Deniel et al 2011). Among them, neurological complications are more frequently reported, including Guillain-Barré syndrome, brachial neuritis, transverse myelitis, cranial nerve palsy and peripheral neuropathy (Kamar et al 2011;Cheung et al 2012;van den Berg et al 2014;Woolson et al 2014). However, such neurological complications as extrahepatic manifestations of clinical or subclinical HEV infection have not yet been reported in the literature in Japan, although cases of autochthonous acute or fulminant hepatitis E are increasingly being seen in this country.…”
Section: Introductionmentioning
confidence: 99%
“…These complications include neurological disorders (Kamar et al 2011;Cheung et al 2012;Santos et al 2013;van den Berg et al 2014;Woolson et al 2014), myasthenia gravis (Belbezier et al 2014), thrombocytopenia (Fourquet et al 2010), aplastic anemia (Shah et al 2012) glomerulonephritis (Kamar et al 2012) and acute pancreatitis (Deniel et al 2011). Among them, neurological complications are more frequently reported, including Guillain-Barré syndrome, brachial neuritis, transverse myelitis, cranial nerve palsy and peripheral neuropathy (Kamar et al 2011;Cheung et al 2012;van den Berg et al 2014;Woolson et al 2014). However, such neurological complications as extrahepatic manifestations of clinical or subclinical HEV infection have not yet been reported in the literature in Japan, although cases of autochthonous acute or fulminant hepatitis E are increasingly being seen in this country.…”
Section: Introductionmentioning
confidence: 99%
“…There is, however, an increasing concern with the persistence of HEV, particularly gt 3 viruses, in individuals with weakened immune systems, resulting in accelerated progression to cirrhosis (7,8). In addition, extrahepatic manifestations have been reported, raising the possibility that infection involves multiple cell types (9). Because HEV gt 3 infection appears to be more common than expected and sometimes can persist, the possibility of transmission through the blood supply has been recognized recently (10).…”
mentioning
confidence: 99%
“…Although it is a common cause of self-limited acute viral infection, HEV infection is often unrecognized or misdiagnosed with drug-induced liver injury [16]. Hepatitis E virus infection may cause decompensation in patients with underlying chronic liver disease, in whom the prognosis is poor [6,16], and is responsible for up to 10-15% of cases of acute liver failure. A recent study shows that from five HEV infected patients with underlying chronic liver injury, three died of acute-onchronic liver failure [6].…”
Section: Discussionmentioning
confidence: 99%
“…Hepatitis E virus infection may cause decompensation in patients with underlying chronic liver disease, in whom the prognosis is poor [6,16], and is responsible for up to 10-15% of cases of acute liver failure. A recent study shows that from five HEV infected patients with underlying chronic liver injury, three died of acute-onchronic liver failure [6]. Treatment with ribavirin may be effective for these patients [17].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation